Cargando…
The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections
Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus, responsible for outbreaks of a severe respiratory illness in humans with a fatality rate of 30%. Currently, there are no vaccines or United States food and drug administration (FDA)-approved therapeutics for humans. The spi...
Autores principales: | Jang, Tae-Ho, Park, Woo-Jung, Lee, Hansaem, Woo, Hye-Min, Lee, So-young, Kim, Kyung-Chang, Kim, Sung Soon, Hong, Eunmi, Song, Jaeyoung, Lee, Joo-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786824/ https://www.ncbi.nlm.nih.gov/pubmed/35075213 http://dx.doi.org/10.1038/s41598-022-05318-4 |
Ejemplares similares
-
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus
por: Choi, Jang-Hoon, et al.
Publicado: (2020) -
Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning
por: Kim, Yoonji, et al.
Publicado: (2019) -
Time Course Evaluation of Enzyme-Linked Immunosorbent Assays Based on Cell-Free Recombinant Proteins for Detection of Antibodies against Middle East Respiratory Syndrome Coronavirus
por: Kim, Jun Won, et al.
Publicado: (2022) -
Guidelines for the Laboratory Diagnosis of Middle East Respiratory Syndrome Coronavirus in Korea
por: Lee, Hyukmin, et al.
Publicado: (2016) -
Collaborative Intervention of Middle East Respiratory Syndrome: Rapid Response Team
por: Lee, Jacob, et al.
Publicado: (2016)